Bhakare Super Speciality Hospital And Research Institute Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 19-12-2024
- Paid Up Capital ₹ 1.00 M
as on 19-12-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2018
About Bhakare Super Speciality Hospital And Research Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Seema Rahane, Nikhil Bhakare, Vasanti Shinde, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74999PN2017PTC172269
- Company No.
172269
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2017
- Date of AGM
31 Dec 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bhakare Super Speciality Hospital And Research Institute?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Rahane  | Director | 01-Jul-2019 | Current |
| Nikhil Bhakare | Director | 30-Aug-2017 | Current |
| Vasanti Shinde | Director | 01-Jul-2019 | Current |
| Merlin Varghese | Director | 31-Jul-2018 | Current |
| Pratiksha Kachi | Director | 31-Jul-2018 | Current |
| Chetan Khopade | Director | 30-Aug-2017 | Current |
Financial Performance of Bhakare Super Speciality Hospital And Research Institute.
Bhakare Super Speciality Hospital And Research Institute Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bhakare Super Speciality Hospital And Research Institute?
In 2018, Bhakare Super Speciality Hospital And Research Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bhakare Super Speciality Hospital And Research Institute?
Unlock and access historical data on people associated with Bhakare Super Speciality Hospital And Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhakare Super Speciality Hospital And Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhakare Super Speciality Hospital And Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
